The supplement, Souvenaid®, is taken once a day as a beverage. Participants must be 50 years of age and be available to participate in the 28-week study, which requires six visits to the IU Medical Center.
For more information about this or other clinical studies for Alzheimer’s disease at the IU School of Medicine, contact Julie Dickson, RN, at 317-278-4333 or call toll free at 866-257-0195.